For: | Chen LX, Zou SJ, Li D, Zhou JY, Cheng ZT, Zhao J, Zhu YL, Kuang D, Zhu XH. Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis. World J Gastroenterol 2020; 26(48): 7664-7678 [PMID: 33505143 DOI: 10.3748/wjg.v26.i48.7664] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v26/i48/7664.htm |
Number | Citing Articles |
1 |
Aditi A. Shirke, Jing Wang, Gopolakrishnan Ramamurthy, Arpan Mahanty, Ethan Walker, Lifang Zhang, Abhiram Panigrahi, Xinning Wang, James P. Basilion. Prostate Specific Membrane Antigen Expression in a Syngeneic Breast Cancer Mouse Model. Molecular Imaging and Biology 2024; doi: 10.1007/s11307-024-01920-2
|
2 |
Scott M. Thompson, Garima Suman, Michael S. Torbenson, Zong‐Ming E. Chen, Danielle E. Jondal, Anurima Patra, Eric C. Ehman, James C. Andrews, Chad J. Fleming, Brian T. Welch, Anil N. Kurup, Lewis R. Roberts, Kymberly D. Watt, Mark J. Truty, Sean P. Cleary, Rory L. Smoot, Julie K. Heimbach, Nguyen H. Tran, Amit Mahipal, Jun Yin, Tyler Zemla, Chen Wang, Zachary Fogarty, Mark Jacobson, Bradley J. Kemp, Sudhakar K. Venkatesh, Geoffrey B. Johnson, David A. Woodrum, Ajit H. Goenka. PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68Ga‐PSMA‐11 PET Using Cyclotron‐Produced 68Ga. Hepatology Communications 2022; 6(5): 1172 doi: 10.1002/hep4.1861
|
3 |
Christine Kang, James Yuheng Jiang, Marco Enoch Lee, Lily Shen, Robert Mansberg. Incidental Intrahepatic Hepatocellular Cholangiocarcinoma Detected on 68Ga-PSMA PET/CT. Clinical Nuclear Medicine 2022; 47(3): e291 doi: 10.1097/RLU.0000000000003992
|
4 |
Sanfeng Han, Tao Ye, Yuqin Mao, Bo Hu, Chen Wang, Tian jiao Wang. Cuproptosis-Related Genes CDK1 and COA6 Involved in the Prognosis Prediction of Liver Hepatocellular Carcinoma. Disease Markers 2023; 2023: 1 doi: 10.1155/2023/5552798
|
5 |
Luca FILIPPI, Arthur J. BRAAT. Theragnostics in primary and secondary liver tumors: the need for a personalized approach. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022; 65(4) doi: 10.23736/S1824-4785.21.03407-5
|
6 |
Vasiliki Zoi, Maria Giannakopoulou, George A. Alexiou, Penelope Bouziotis, Savvas Thalasselis, Andreas G. Tzakos, Andreas Fotopoulos, Athanassios N. Papadopoulos, Athanassios P. Kyritsis, Chrissa Sioka. Nuclear Medicine and Cancer Theragnostics: Basic Concepts. Diagnostics 2023; 13(19): 3064 doi: 10.3390/diagnostics13193064
|
7 |
Veronica Chi Ken Wong, Joshua Yip, Vincenzo Fragomeli, Martin Weltman, Han Loh, Ken Le, Diep Nguyen, Chuong Bui, Robert Mansberg. Comparison between PSMA PET/CT and MRI for Characterizing Hepatocellular carcinoma: A Real-World Study. Tomography 2023; 9(1): 130 doi: 10.3390/tomography9010011
|
8 |
Xin‑Long Chen, Hai‑Chuan Yu, Qi‑Gang Fan, Qi Yuan, Wen‑Kai Jiang, Shao‑Zhen Rui, Wen-Ce Zhou. Comparative effectiveness of interventional therapeutic modalities for unresectable hepatocellular carcinoma: A systematic review and network meta‑analysis. Oncology Letters 2022; 24(4) doi: 10.3892/ol.2022.13486
|
9 |
Xiaoguang Liu, Lixing Chen, Yuying Li, Chuanchuan He, Xiaojuan Zhang, Huimin Zhou, Guangfa Bao, Xiaohua Zhu, Guangya Xiang, Xiang Ma. Synthesis of novel DOTA-/AAZTA-based bifunctional chelators: Solution thermodynamics, peptidomimetic conjugation, and radiopharmaceutical evaluation. Biomedicine & Pharmacotherapy 2023; 165: 115114 doi: 10.1016/j.biopha.2023.115114
|
10 |
Rena X. Li, Yansheng Hao, Mark Ettel. Expression of PSMA in Tumor-Associated Vasculature Predicts Poorer Survival in Patients With Hepatocellular Carcinoma and Is Likely Associated With PD-L1. International Journal of Surgical Pathology 2024; doi: 10.1177/10668969241226705
|
11 |
Shuxian An, Gang Huang, Jianjun Liu, Weijun Wei. PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers. European Journal of Nuclear Medicine and Molecular Imaging 2022; 49(12): 3973 doi: 10.1007/s00259-022-05905-7
|
12 |
Michel Kmeid, Young Nyun Park, Taek Chung, Georgi Lukose, Luz Sullivan, Rupinder Brar, Hwajeong Lee. PSMA Immunohistochemistry in Hepatic Neoplasms. American Journal of Surgical Pathology 2022; 46(12): 1688 doi: 10.1097/PAS.0000000000001971
|
13 |
Alessio Rizzo, Manuela Racca, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia. Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis. Pharmaceuticals 2022; 15(11): 1368 doi: 10.3390/ph15111368
|